03 February 2010 22:12 [Source: ICIS news]
NEW YORK (ICIS news)--Wall Street analysts on Wednesday were subdued in their reaction to US major Dow Chemical’s fourth-quarter earnings and outlook for 2010.
“Dow’s 2010 and 2011 level of earnings per share is likely to be much below mid-cycle earnings of about $3.00. The gap between current earnings and mid-cycle profits is probably an impediment to upward share price movement in 2010,” said JPMorgan analyst Jeffrey Zekauskas in a research note.
The analyst, who maintained his neutral rating on Dow, bumped up his 2010 earnings per share estimate by 25 cents, to $1.25 on a lower expected tax rate, and kept his forecast of $2.25 for 2011.
Dow posted underlying earnings per share of 18 cents in the fourth quarter, beating Wall Street’s consensus of 11 cents.
Net profit came in at $87m (€63m) versus the $1.55bn loss reported in the year-ago period, as sales rose 15% to $12.5bn.
Dow’s fourth-quarter results reflect trends of solid growth in emerging economies and a slower recovery in North America and Europe - trends apparent in the fourth-quarter results of other US chemical companies such as DuPont.Year-over-year volumes in emerging geographies rose 33%. Volumes in China were up 57%, noted BB&T Capital Markets analyst Frank Mitsch, who has a hold rating on Dow.
However, volumes in North America and Europe fell 11% and 4% year over year, respectively.
On a sequential basis, volumes rose in every region except North America, where they declined 1%, Dow said.
“Dow is banking on growth in [emerging market] regions, noting the US and Europe are expected to lag,” Mitsch said.
Dow chairman and CEO Andrew Liveris referred to the economic recovery as a “lazy V”, Mitsch said.
“Our reading of the tea leaves suggests that he was implying that we will not be seeing a V-shaped recovery but rather steady but slow global progress,” he said.
Credit Suisse analyst John McNulty, who has an outperform rating on Dow, called the fourth-quarter performance “decent".
“We remain convinced that Dow offers the greatest upside of any large cap name in chemicals as earnings will be driven by a leaner cost structure, richer than expected R&D pipeline and volume growth tied to the improving economy,” McNulty said.
He maintained his price target of $39 on the stock.
Shares of Dow Chemical rose 1 cent, to $27.58 at the close of trading on Wednesday. The stock closed down $1.06, or 3.7%, to $27.57 on Tuesday after the release of earnings.
($1 = €0.72)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|